SS Innovations International Inc Common Stock (SSII) had the highest return between January 1, 2022 and December 31, 2024 by a mid-cap US stock, returning 98,525%.
| ASSET | DATE | % RETURN |
|---|---|---|
SS Innovations International Inc Common Stock (SSII) | 1/1/2022 - 12/31/2024 | 98,525% |
ADMA Biologics (ADMA) | 1/1/2022 - 12/31/2024 | 1,125% |
Modine Manufacturing (MOD) | 1/1/2022 - 12/31/2024 | 1,033.24% |
Vista Oil Gas ADR (VIST) | 1/1/2022 - 12/31/2024 | 920.94% |
Banco Macro SA B ADR (BMA) | 1/1/2022 - 12/31/2024 | 797.22% |
Viking Therapeutics (VKTX) | 1/1/2022 - 12/31/2024 | 761.67% |
BBVA Banco Frances SA ADR (BBAR) | 1/1/2022 - 12/31/2024 | 708.79% |
Powell Industries (POWL) | 1/1/2022 - 12/31/2024 | 701.06% |
Grupo Financiero Galicia SA ADR (GGAL) | 1/1/2022 - 12/31/2024 | 696.5% |
Soleno Therapeutics (SLNO) | 1/1/2022 - 12/31/2024 | 605.1% |
Verona Pharma PLC ADR (VRNA) | 1/1/2022 - 12/31/2024 | 583.95% |
Fortress Transp & Infra Inv (FTAI) | 1/1/2022 - 12/31/2024 | 555.75% |
Transportadora de Gas del Sur SA ADR (TGS) | 1/1/2022 - 12/31/2024 | 554.81% |
Sterling Construction (STRL) | 1/1/2022 - 12/31/2024 | 534.46% |
Biohaven Pharmaceutical (BHVN) | 1/1/2022 - 12/31/2024 | 522.5% |
Carpenter Technology (CRS) | 1/1/2022 - 12/31/2024 | 502.58% |
Rhythm Pharmaceuticals (RYTM) | 1/1/2022 - 12/31/2024 | 459.8% |
Credo Technology (CRDO) | 1/1/2022 - 12/31/2024 | 455.45% |
MoonLake Immunotherapeutics (MLTX) | 1/1/2022 - 12/31/2024 | 446.97% |
United States Lime & Minerals (USLM) | 1/1/2022 - 12/31/2024 | 415.05% |
Belite Bio Inc ADR (BLTE) | 1/1/2022 - 12/31/2024 | 404.8% |
F&G Annuities & Life (FG) | 1/1/2022 - 12/31/2024 | 336.6% |
Abercrombie & Fitch (ANF) | 1/1/2022 - 12/31/2024 | 324.63% |
Nuvalent (NUVL) | 1/1/2022 - 12/31/2024 | 322.22% |
Pampa Energia SA ADR (PAM) | 1/1/2022 - 12/31/2024 | 316.58% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
